Srax, inc. (SRAX)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12
Cash Flows From Operating Activities
Net income (loss)

-14,076

-16,859

-20,991

-1,129

2,946

8,744

10,409

-13,544

-11,047

-13,032

-7,524

-7,217

-3,820

-4,248

-3,330

-1,613

-3,071

-2,723

-4,223

-4,482

-5,778

-4,411

-2,748

-2,660

-2,058

-1,747

-1,950

-1,437

-1,409

-1,258

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Accretion of put warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain (loss) on sale of assets

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of stock based prepaid fees

-

-

-

-

-

-

-

-

-

-

-

-

-

373

532

634

634

634

634

634

644

654

647

554

396

237

95

39

39

58

0

0

0

Stock based compensation

1,306

1,167

897

1,163

1,833

1,879

2,895

2,626

1,739

2,085

1,537

1,361

1,434

1,200

824

853

860

840

1,594

1,502

1,396

1,203

373

706

659

631

503

94

69

41

0

0

0

Gain/Loss on valuation of warrant derivatives

-

-

-

-

-

-

-

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on sale of SRAXmd

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of debt issue costs

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of derivative liabilities

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of debt issuance costs

-

-

-

-

-

-

1,047

949

598

1,082

625

943

1,359

1,076

1,144

1,191

1,227

1,252

0

0

0

-

-

-

239

274

274

147

34

0

0

0

0

Amortization of debt discount

-

-

-

-

-

4,295

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

PIK Interest expense accrued to principal

-

-

-

-

-

-

-

-

-

-

-

-

-

511

558

454

422

390

342

239

151

63

0

0

0

-

-

-

-

-

-

-

-

Digital currency assets impairment loss

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accretion of contingent consideration

-

-

-

-

-

-

-

-

-

-

-

-

-

-3,585

-3,424

560

751

853

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

Accretion of put liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

Accretion of put liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation and amortization

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Provision for bad debts

0

-

-

-

-

-12

-40

-179

-187

-195

-140

20

105

119

116

112

85

86

93

77

33

26

0

0

0

-

-

-

-

-

-

-

-

Depreciation expense

77

74

66

57

50

44

39

36

29

22

18

14

15

21

0

0

0

-

-

-

-

-

12

10

8

7

6

6

4

3

0

0

0

Amortization of intangibles

-

-

-

-

-

-

-

0

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of intangibles

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities
Accounts receivable

-635

-1,638

-606

-136

376

-960

-4,700

-5,056

-5,035

-4,261

2,672

4,203

7,028

6,817

953

-234

1,028

3,287

6,039

6,664

1,722

1,196

219

-46

30

388

91

-216

-561

-758

0

0

0

Prepaid expenses

10

106

87

251

167

215

123

191

210

135

313

1

26

23

96

180

126

86

54

81

143

170

70

54

28

46

-85

-67

-58

0

0

0

0

Other current assets

-56

-81

9

181

180

214

0

0

0

-

-

-

-

-29

-15

4

8

28

-8

-24

-24

-17

6

2

2

0

0

-0

-0

-0

0

0

0

Other assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10

10

4

4

0

1

1

1

0

0

0

0

-

-

-

-

Accounts payable and accrued expenses

-1,362

-2,214

-2,986

-6,606

-3,223

-3,103

-8,819

-3,335

-6,518

-6,535

944

3,762

8,756

8,020

5,776

526

1,021

2,254

3,847

6,293

1,706

861

-437

-245

-139

513

843

141

-27

-133

0

0

0

Unearned revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-1

17

22

-4

-24

1

22

8

25

0

0

0

-

-

-

-

-

-

-

-

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

462

1,445

739

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net Cash Used in Operating Activities

-15,210

-15,350

-17,297

-21,601

-16,049

-13,663

-11,047

-2,594

-4,308

-4,367

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-917

-478

-195

-689

-709

-570

0

0

0

Cash Flows From Investing Activities
Proceeds from sale of SRAXmd, net

-

570

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of property and equipment

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of equipment

-

-

-

-

-

82

54

128

136

121

125

42

38

32

0

0

0

-

-

-

-

6

26

26

26

19

0

0

0

-

-

-

-

Development of software

1,290

1,292

1,151

1,053

1,009

961

882

815

731

634

573

389

254

119

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sale of SRAXmd

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-38

-33

-33

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net Cash Used by Investing Activities

-1,180

-795

-1,082

22,145

22,321

21,875

22,021

-944

-890

-756

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-26

-19

0

0

0

-

-

-

-

Cash Flows From Financing Activities
Proceeds from issuance of notes payable less issuance costs

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from the issuance of common stock units

-

-

-

-

-

-

-

-

-

4,020

4,912

7,963

7,963

4,643

0

0

0

-

-

-

2,677

3,950

3,709

3,709

3,709

2,436

0

0

0

472

0

0

0

Repayments of notes payable

-

-

-

-

-

-

-

-

-

3,996

5,997

6,393

7,394

3,763

4,965

5,164

4,414

4,364

1,162

567

315

0

371

413

492

550

178

136

57

0

0

0

0

Cost of common stock sale

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Cost of common stock sale

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5

0

0

0

-

-

-

-

Proceeds from warrant offering

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

9

2

0

0

0

-

-

-

-

-

-

-

-

Proceeds from notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

2,100

3,500

5,000

5,000

2,900

0

0

0

-

-

-

-

486

486

486

257

0

0

0

0

Payment of contingent consideration

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Debt issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

36

36

36

25

0

0

0

0

Net cash provided by (used in) financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,264

-514

-1,457

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net Cash Provided by Financing Activities

0

-

-

-

-

-

-

-

-

5,092

0

0

0

-

-

-

-

-

-

-

-

-

-

-

3,190

2,108

257

314

174

472

0

0

0

Net increase (decrease) in Cash

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net increase / (decrease) in cash and cash equivalents

-

-

-

-

-

-

-

-355

70

-31

-4,024

-278

-1,481

-42

3,208

-840

897

-752

456

-24

-1,600

128

430

1,506

2,246

1,609

61

-375

-552

-115

0

0

0

Supplemental disclosure of cash flow information:
Cash paid for interest

132

136

912

1,317

1,246

1,531

1,327

882

1,007

1,217

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,277

1,238

1,133

875

620

379

157

0

19

34

38

37

18

3

0

0

0

0

Cash paid for taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

-38

-38

-38

-38

38

38

0

0

0

Noncash investing and financing activities:
Vesting of prepaid common stock award

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Relative fair value of warrants issued with term loan

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Shares of common stock issued for extension agreement

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Common stock issued for vested grants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Put liability on issuance of warrants

-

-

-

-

-

-

-

-

-

-

2,500

2,500

2,500

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Fees and costs deducted from proceeds of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

63

63

63

42

0

0

0

0

Common stock issued as payment of financing fee

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

175

175

175

100

0

0

0

0

Issuance of common stock to be issued

-

-

-

-

-

880

0

0

0

-

-

-

0

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Common stock issued for preferred stock conversion and vesting grants

-

-

-

-

-

-

-

-

-

-

0

0

0

2,400

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Vesting of common stock award

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contribution of member interests (net assets) in Social Reality, LLC in exchange for common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

722

0

0

0